Drano, not sure why you are posting so often and insistently that the company should give away thousands of courses of the drug to the Philippines. This is CYDY's first revenue! It's one thing for Gilead to reduce the price of RemDeceiver now -- after making many billions of dollars on it -- and is efficacy has been shown to be almost worthless. It's quite another for a company that is borrowing money for a stiff price to basically chuck away the chance to make some money and fund trials for other indications. How do you think the market would react to a headline saying that CYDY is shooting itself in the foot by giving away the drug? Aww, that's nice of them. Sell sell sell.
I agree with NP: keep the price as low as possible, while you still make money off of it. Save people. But also save CYDY.